原发性脾脏恶性淋巴瘤手术治疗26例临床分析
DOI:
CSTR:
作者:
作者单位:

福建医科大学 附属协和医院肝胆外科,福州350001

作者简介:

通讯作者:

中图分类号:

R733.41

基金项目:


Clinical Analysis Of 26 Primary Splenic Lymphoma Cases Undergoing Surgical Treatment
Author:
Affiliation:

Department of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou 350001,China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的分析原发性脾脏恶性淋巴瘤的临床特点及诊治方法。方法回顾性分析2003年1月-2013年6月收治的原发性脾脏恶性淋巴瘤患者的临床资料及随访结果。结果主要临床表现为左上腹痛或腹部不适(68.38%)、发热(46.15%)、贫血(46.15%)、脾肿大(100%);术后病理提示霍奇金淋巴瘤1例(3.85%),非霍奇金淋巴瘤25例(96.15%),根据Ahmann分期,Ⅰ期6例(23.08%),Ⅱ期5例(19.23%),Ⅲ期15例(57.69%);本组病例1年、5年总生存率分别为60%、30%。结论原发性脾脏恶性淋巴瘤是临床少见的淋巴瘤,早期手术联合术后辅助化疗可提高生存率,并有益于进一步明确诊断,既是诊断手段又是治疗手段。

    Abstract:

    ObjectiveTo investigate the clinical features and the treatment of primary splenic lymphoma.MethodsThe clinical data and followup surveys of 26 cases with primary splenic lymphoma, treated from January 2003 to June 2013, were analyzed retrospectively.ResultsLeft upper abdominal pain(68.38%), fever(46.15% ), anemia(46.15%), and spleonmegaly(100%) were the main clinical symptoms.Histopathology showed that nonHodgkin lymphoma accounted for 25 of the cases (96.15%) and 1 case was of Hodgkin’s Lymphoma.Based on the Ahmann clinical staging of splenic lymphoma, the stageⅠ disease accounted for 6 of the patients (23.08%), stage Ⅱ accounted for 5 (19.23%), and stage Ⅲ accounted for 15 (57.69%).The 1year and 5year overall survival rates were 60% and 30%.ConclusionsPrimary splenic lymphoma is a rare lymphoma, surgery to remove even multivisceral resection can improve the survival rate, and conducive to the further diagnosis.

    参考文献
    相似文献
    引证文献
引用本文

叶敬旻, 陈燕凌.原发性脾脏恶性淋巴瘤手术治疗26例临床分析[J].福建医科大学学报自然版,2014,(4):277-278

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
文章二维码